These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14657779)

  • 1. ECT resistance and early relapse: two cases of subsequent response to venlafaxine.
    Iodice AJ; McCall WV
    J ECT; 2003 Dec; 19(4):238-41. PubMed ID: 14657779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizure activity and safety in combined treatment with venlafaxine and ECT: a pilot study.
    Bernardo M; Navarro V; Salvà J; Arrufat FJ; Baeza I
    J ECT; 2000 Mar; 16(1):38-42. PubMed ID: 10735330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy.
    Kopecek M; Cerná L; Sulak J; Raszka M; Bares M; Seifertová D
    Neuro Endocrinol Lett; 2007 Dec; 28(6):889-94. PubMed ID: 18063943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid onset of antidepressant activity with venlafaxine.
    Weisler RH; van Meter S
    J Clin Psychiatry; 2002 Jun; 63(6):534-5; author reply 535-6. PubMed ID: 12088168
    [No Abstract]   [Full Text] [Related]  

  • 5. Venlafaxine: a new antidepressant drug.
    Holdcroft C
    Nurse Pract; 1994 Sep; 19(9):21. PubMed ID: 7816367
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of venlafaxine-ECT combination in treatment-resistant depression.
    Gonzalez-Pinto A; Gutierrez M; Gonzalez N; Elizagarate E; Perez de Heredia JL; Mico JA
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):206-9. PubMed ID: 11983797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic profile and efficacy of venlafaxine.
    Mendlewicz J
    Int Clin Psychopharmacol; 1995 Mar; 10 Suppl 2():5-13. PubMed ID: 7622816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroconvulsive therapy in the treatment-resistant patient.
    Devanand DP; Sackeim HA; Prudic J
    Psychiatr Clin North Am; 1991 Dec; 14(4):905-23. PubMed ID: 1771153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression.
    Sackeim HA; Prudic J; Devanand DP; Decina P; Kerr B; Malitz S
    J Clin Psychopharmacol; 1990 Apr; 10(2):96-104. PubMed ID: 2341598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine: loss of antidepressant effect and its management.
    Sharma V
    J Clin Psychiatry; 1998 Jul; 59(7):381-2. PubMed ID: 9714268
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy.
    Prudic J; Haskett RF; McCall WV; Isenberg K; Cooper T; Rosenquist PB; Mulsant BH; Sackeim HA
    J ECT; 2013 Mar; 29(1):3-12. PubMed ID: 23303417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects.
    Sackeim HA; Dillingham EM; Prudic J; Cooper T; McCall WV; Rosenquist P; Isenberg K; Garcia K; Mulsant BH; Haskett RF
    Arch Gen Psychiatry; 2009 Jul; 66(7):729-37. PubMed ID: 19581564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients.
    Thase ME
    J Clin Psychiatry; 1998 Oct; 59(10):502-8. PubMed ID: 9818630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined use of bupropion, lithium, and venlafaxine during ECT: a case of prolonged seizure activity.
    Conway CR; Nelson LA
    J ECT; 2001 Sep; 17(3):216-8. PubMed ID: 11528316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation therapy following ECT: directions for future research.
    Sackeim HA
    Psychopharmacol Bull; 1994; 30(3):501-21. PubMed ID: 7878189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional brain circuits in major depression and remission.
    Sackeim HA
    Arch Gen Psychiatry; 2001 Jul; 58(7):649-50. PubMed ID: 11448370
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged bradycardia complicates antidepressive treatment with venlafaxine and ECT.
    Agelink MM; Zeit T; Klieser E
    Br J Psychiatry; 1998 Nov; 173():441. PubMed ID: 9926067
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings.
    Martin SD; Martin E; Rai SS; Richardson MA; Royall R
    Arch Gen Psychiatry; 2001 Jul; 58(7):641-8. PubMed ID: 11448369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression.
    Fatemi SH; Emamian ES; Kist DA
    Ann Pharmacother; 1999 Jun; 33(6):701-3. PubMed ID: 10410184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: a chart review.
    Nakajima S; Ishida T; Akaishi R; Takahata K; Kitahata R; Uchida H; Suzuki T; Takeuchi H; Nomura K; Nakagawa A; Watanabe K; Kashima H
    J ECT; 2009 Sep; 25(3):178-81. PubMed ID: 19710625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.